海外の治験の状況「1」での検索結果
2657件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
- Pulmonary Arterial Hypertension
- Australia, Hungary, United States
- 2012-11-08
Not Recruiting
- A Study to Compare Efficacy in Terms of Plasma HIV-1 RNA Between 2 Fixed Dose Combinations After a Switch in Fully Suppressed Patients
- HIV/AIDS;HIV/AIDS
- Uganda
- 2012-10-19
Not Recruiting
- Phase 3b, Randomized, Open-label Study Of Bevacizumab + Temsirolimus Vs. Bevacizumab + Interferon-alfa As First-line Treatment In Subjects With Advanced Renal Cell Carcinoma
- Renal Cell Carcinoma;C64 - Malignant neoplasm of kidney, except renal pelvis
- Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, France, Germany, Hong Kong, Hungary, India, Italy, Korea, Republic of, Malaysia, Mexico, Netherlands, Poland, Portugal, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Taiwan, Province of China, Ukraine, United Kingdom, United States
- 2012-10-16
Not Recruiting
- A Phase 3, Randomized Study Of SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
- Carcinoma, Renal Cell;C64 - Malignant neoplasm of kidney, except renal pelvis
- Australia, Brazil, Canada, France, Germany, Italy, Poland, Russian Federation, Spain, United Kingdom, United States
- 2012-10-10
Not recruiting
- Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)
- Chronic Obstructive Pulmonary Disease;Chronic Obstructive Pulmonary Disease;Chronic Obstructive Pulmonary Disease;Chronic Obstructive Pulmonary Disease
- Australia, New Zealand, United States
- 2013-05-13
Not recruiting
- Haploidentical donor stem cell transplantation for haematological malignancies - a Phase 1/2 pilot study in an Australian population
- Haematological malignancies
- Australia
- 2013-03-27
Authorised
- Assess the effect of switching HIV-1 infected subjects with CNS toxicity (= Grade 2) from ATRIPLA™ or its complements to MK-1439A
- Human Immunodeficiency Virus-1 infection MedDRA version: 20.1 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Ireland, South Africa, United Kingdom
- 2015-11-20
Recruiting
- Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda
- Severe Illness;Septicaemia;Diarrhoea;Malaria;Lower Respiratory Infection
- Uganda
- 2015-11-12
Recruiting
- Open Sinus Lift Technique With Simultaneous Implantation Using Platelet Rich Fibrin (PRF) Versus Nano-crystalline Hydroxyapatite
- Atrophied Posterior Maxillary Ridge
- Egypt
- 2015-10-13
Not recruiting
- A Phase 0 Open-labelled Clinical Trial To Investigate The Safety of a Micro-dose of a Nanocelle'Trademark' Insulin Formulation Administered Oro-buccally in Healthy Adult Volunteers.
- Diabetes
- Australia
- 2016-08-10
Not recruiting
- Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
- Type 2 Diabetes Mellitus;Type 2 Diabetes Mellitus;Type 2 Diabetes Mellitus;Type 2 Diabetes Mellitus
- Cameroon
- 2016-07-12
Not Recruiting
- Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin
- Type 2 diabetes mellitus
- Algeria, China, Hong Kong, India, Taiwan, Turkey, Ukraine
- 2016-05-26
Not recruiting
- The Evaluation Of Bone Width Gain Following Split Crest Technique With Or Without Platelet Rich Fibrin( PRF)
- Ridge Deficiency;Ridge Deficiency;Ridge Deficiency;Ridge Deficiency
- Egypt
- 2017-01-19
Not Recruiting
- A structured approach to home glucose monitoring for type 2 diabetes patients using insulin
- Type 2 diabetes mellitus Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus
- South Africa
- 2017-01-16
Recruiting
- Safety and Efficacy of NA-1 in Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1)
- Stroke, Acute;Stroke, Acute;Stroke, Acute
- Australia, Canada, Germany, Ireland, Korea, Republic of, Sweden, United Kingdom, United States
- 2016-10-06
Recruiting
- ?Efficacy of Insulin Versus Hyalase Hydro-dissection of Median Nerve in Rheumatoid Arthritis Patients
- Treatment Resistant Carpal Tunnel in RA Patients
- Egypt
- 2017-12-25
Not recruiting
- Comparison of Kinesiotaping and Pressure Garment on Women With Upper Extremity Lymphedema Following Mastectomy
- Breast Cancer Lymphedema
- Egypt
- 2017-12-25
Authorised
- Study to evaluate safety and effectiveness of NA-1 in reducing disability in stroke patients selected for mechanical clot removal procedures.
- Acute Ischemic Stroke (AIS) in adult subjects with a large intracranial arterial occlusion, a small ischemic core, and good collaterals. MedDRA version: 20.0 Level: PT Classification code 10061256 Term: Ischaemic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.1 Level: LLT Classification code 10055221 Term: Ischemic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.0 Level: LLT Classification code 10023027 Term: Ischaemic stroke NOS System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.1 Level: LLT Classification code 10074321 Term: Nonhaemorrhagic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.1 Level: LLT Classification code 10074318 Term: Nonhemorrhagic stroke System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Canada, Germany, Ireland, Korea, Republic of, Sweden, United Kingdom, United States
- 2017-12-18
Not recruiting
- Comparison of pharmacokinetics, safety, tolerability, and pharmacodynamics (PK/PD) of Stelis Teriparatide [rh-PTH (1-34)] with Forsteo® and Forteo® in healthy volunteers
- OSTEOPOROSIS
- Australia
- 2018-01-10
Recruiting
- A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
- Crohn's Disease
- American Samoa, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-11-15